Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/10/2012CN101198624B IL-31 monoclonal antibodies and methods of use
10/10/2012CN101193912B Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof
10/10/2012CN101163718B Reagents that bind ccx-ckr2
10/10/2012CN101151276B Method of producing protein by using hamster IGF-1
10/10/2012CN101128487B Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
10/10/2012CN101128215B Immunogenic composition for use in vaccination against staphylococcei
10/10/2012CN101124244B Human monoclonal antibodies against CD25
10/09/2012US8283518 Administration of transposon-based vectors to reproductive organs
10/09/2012US8283451 Kit for prediction of pre-eclampsia
10/09/2012US8283440 Snapin and methods for regulation of microtubule assembly and dendrite growth and branching
10/09/2012US8283138 Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins
10/09/2012US8283131 Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock
10/09/2012US8283123 Methods of determination of activation or inactivation of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) hormonal systems
10/09/2012US8282934 Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
10/09/2012US8282933 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease
10/09/2012US8282929 Methods of treating a disease with anti-C5 alpha antibodies
10/09/2012US8282925 Method for treating rheumatoid arthritis using anti-S100A9 antibody
10/09/2012US8282924 Hybrid antibodies
10/09/2012US8282923 Antibodies which bind and inhibit blood factor VIII
10/09/2012US8282922 Method of treating an auto-inflammatory syndrome with a human IL-1β binding antibody
10/09/2012CA2494197C Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
10/09/2012CA2476901C Anti-ccr5 antibody
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2432377C Focused libraries of genetic packages
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2323751C Diagnostics and vaccines for mycobacterial infections of animals and humans
10/09/2012CA2229204C Deubiquitinating enzymes that regulate cell growth
10/04/2012WO2012135831A1 Cell-penetrating anti-dna antibodies and uses thereof inhibit dna repair
10/04/2012WO2012135740A2 Cd37-binding molecules and immunoconjugates thereof
10/04/2012WO2012135666A1 Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
10/04/2012WO2012135589A1 Methods of administering beta7 integrin antagonists
10/04/2012WO2012135360A1 Binding proteins specific for egfr expressed on tumor and uses thereof
10/04/2012WO2012135345A1 Dual variable region antibody-like binding proteins having cross-over binding region orientation
10/04/2012WO2012135332A1 Modulators of plexin b2 activity
10/04/2012WO2012135284A2 Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes
10/04/2012WO2012135132A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012WO2012135035A1 Anti - sclerostin antibody crystals and formulations thereof
10/04/2012WO2012134039A1 Protein having antigen activity against liver flukes
10/04/2012WO2012133898A1 Antibody reacting with native cochlin-tomoprotein (ctp) and method for measuring ctp using same
10/04/2012WO2012133814A1 Therapeutic agent for cancer, and method for determining prognosis of cancer
10/04/2012WO2012133782A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012WO2012133735A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
10/04/2012WO2012133572A1 Method for selecting plasma cells and plasmablasts, method for producing target antigen-specific antibody, and new monoclonal antibody
10/04/2012WO2012132067A1 Retention of antigen-binding molecules in blood plasma and method for modifying immunogenicity
10/04/2012WO2012131555A2 Hetero-dimeric immunoglobulins
10/04/2012WO2012131078A1 Bispecific binding molecules binding to vegf and ang2
10/04/2012WO2012131076A1 BISPECIFIC BINDING MOLECULES BINDING TO Dll4 AND Ang2
10/04/2012WO2012131053A1 Methods of treating immune disorders with single domain antibodies against tnf-alpha
10/04/2012WO2012131004A2 Antibodies directed against icos and uses thereof
10/04/2012WO2012130874A1 Bispecific anti-cxcr7 immunoglobulin single variable domains
10/04/2012WO2012130872A1 Method for producing solid formulations comprising immunoglobulin single variable domains
10/04/2012WO2012130834A1 Anticoagulant antidotes
10/04/2012WO2012130831A1 Antibody fc variants
10/04/2012WO2012130471A1 Recombinant tnf ligand family member polypeptides with antibody binding domain and uses thereof
10/04/2012WO2012129668A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012WO2012109538A8 Surrogates of post-translationally modified proteins and uses thereof
10/04/2012WO2012109285A3 Antibodies that specifically bind staphylococcus aureus alpha toxin and methods of use
10/04/2012WO2012109282A3 Methods and systems for treating or preventing pregnancy-related hypertensive disorders
10/04/2012WO2012093127A3 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
10/04/2012WO2012092539A3 Antibodies to dll4 and uses thereof
10/04/2012WO2012088094A3 Il-1 binding proteins
10/04/2012WO2012080926A3 Anti-notch1 antibodies
10/04/2012WO2012078752A3 Serine protease inhibitor kazal antibodies
10/04/2012WO2012075422A3 Compositions and methods for treating amyloid plaque associated symptoms
10/04/2012WO2012058393A3 Dkk1 antibodies and methods of use
10/04/2012US20120253020 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
10/04/2012US20120253019 Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
10/04/2012US20120253018 Bovine Adeno-Associated Viral (BAAV) Vector and Uses Thereof
10/04/2012US20120253017 Stem cell targeting
10/04/2012US20120253016 Antibody molecules that bind to il-6 receptor
10/04/2012US20120252884 Modified and Stabilized GDF Propeptides and Uses Thereof
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252701 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120252040 Kit for diagnosing prostate cancer and diagnosis method
10/04/2012US20120252036 Diagnostic tests for abnormal ovarian conditions
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251559 Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates
10/04/2012US20120251558 Antibody-drug conjugates
10/04/2012US20120251557 GalNAc-SPECIFIC BINDING MOLECULES AND USES THEREOF
10/04/2012US20120251555 Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
10/04/2012US20120251554 Anti-cd33 antibodies and use thereof for immunotargeting in treating cd33-associated illnesses
10/04/2012US20120251552 Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
10/04/2012US20120251550 Crystalline anti-hTNFalpha antibodies
10/04/2012US20120251549 Complement inhibitors and uses thereof
10/04/2012US20120251547 Il-17 receptor a antigen binding proteins
10/04/2012US20120251544 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
10/04/2012US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
10/04/2012US20120251540 Stabilized single domain antibodies
10/04/2012US20120251535 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251534 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody
10/04/2012US20120251532 Anti-alpha v beta 6 antibodies
10/04/2012US20120251531 ANTIBODY Fc VARIANTS
10/04/2012US20120251529 Anti-cea antibodies
10/04/2012US20120251527 Podocyte specific assays and uses thereof
10/04/2012US20120251454 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses
10/04/2012CA2831907A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
10/04/2012CA2831867A1 Therapeutic agent for cancer, and method for determining prognosis of cancer
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 1494